CG
RPTP

Cutler Group’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Cutler Group’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-122,400
Closed -$19K – 8095
2016
Q3 		$19K Buy
122,400
+100,700
+464% +$716K ﹤0.01% 3511
2016
Q2 		$9K Buy
21,700
+13,200
+155% +$67.7K ﹤0.01% 4371
2016
Q1 		$1K Sell
8,500
-69,600
-89% -$280K ﹤0.01% 6371
2015
Q4 		$6K Buy
+78,100
New +$453K ﹤0.01% 4832

Cutler Group's RPTP Position: Q4 2016 in Review

Cutler Group sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 6,126 shares — an estimated $54K sold.

Cutler Group first reported a position in RPTP in Q4 2015 and held it in 4 quarters. The position peaked at $296K in Q4 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Cutler Group reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Cutler Group sold 6,126 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $54K.
  • Cutler Group first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2015 and held it in 4 quarters.
  • Cutler Group's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $296K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Cutler Group's 13F filing for Q4 2016, filed 12 Jan 2017.